NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered GHK-Cu from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply
+5 more ↓
87%
Finnrick rating
#74 of 156 GHK-Cu vendors
45 of 52 classifiable tests passed
customers 4.7★ (31)
methodology · Purity focus
Finnrick analysis · GHK-Cu

HK Peptides' GHK-Cu is mostly high-purity, but recurring fill outliers hold the score down, including +505%, +60%, +55% and +40%, plus one failed identity. Recent results look steadier; batch-tagged, on-target fills are the key follow-up.

methodology →
vendor intelligence report
Vendor Intelligence Report: HK Peptides

Corporate records tie the storefront’s history to a mainland entity now shown as deregistered, while the live HK Peptide Ltd counterparty remains unresolved. The report maps lookalikes, copied web text, WHOIS trails, payment rails, and an anti-scam phone contradiction.

38 pages5 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cuselected
$0.07
87%
52
2
Retatrutide
$1.00
86%
146
3
Tirzepatide
$0.40
83%
136
4
PT-141
-
73%
7
5
BPC-157
$0.82
73%
23
6
Melanotan II
$0.41
68%
12
7
Semaglutide
$0.70
62%
12
8
Cagrilintide
$2.30
59%
11
9
Ipamorelin
$0.81
55%
14
10
Tesamorelin
$1.78
48%
34
11
Sermorelin
$1.57
45%
6
12
TB-500
$1.76
44%
10
13
CJC-1295
$1.90
29%
10
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%16 Jul 2025: 86%4 Aug 2025: 87%4 Aug 2025: 83%4 Aug 2025: 83%18 Sep 2025: 84%21 Oct 2025: 86%23 Oct 2025: 87%6 Nov 2025: 83%17 Nov 2025: 83%6 Dec 2025: 84%17 Dec 2025: 85%17 Dec 2025: 85%17 Dec 2025: 86%6 Jan 2026: 87%6 Jan 2026: 87%19 Jan 2026: 88%19 Jan 2026: 89%19 Jan 2026: 89%19 Jan 2026: 89%26 Jan 2026: 90%26 Jan 2026: 87%26 Jan 2026: 87%2 Feb 2026: 88%2 Feb 2026: 88%9 Feb 2026: 88%9 Feb 2026: 89%11 Feb 2026: 89%11 Feb 2026: 89%18 Feb 2026: 90%18 Feb 2026: 87%20 Feb 2026: 87%22 Feb 2026: 88%22 Feb 2026: 88%26 Feb 2026: 88%2 Mar 2026: 89%12 Mar 2026: 89%12 Mar 2026: 87%18 Mar 2026: 87%18 Mar 2026: 87%29 Mar 2026: 88%28 Apr 2026: 86%28 Apr 2026: 86%5 May 2026: 86%5 May 2026: 87%5 May 2026: 87%20 Jul 2026: 85%3 Aug 2026: 85%3 Aug 2026: 86%15 Sep 2026: 86%24 Sep 2026: 86%6 Oct 2026: 86%12 Oct 2026: 87%15 Nov 2026: current 87%86%87%87%Jul 25Nov 26
Showing GHK-Cu tests only
Peptide testing

Ordered GHK-Cu from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply
HK Peptides GHK-Cu test history
COA-backed lab tests
1-10 of 52

About HK Peptides test results from Finnrick

HK Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 473 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HK Peptides peptides in this dataset are BPC-157 (23 tests) and Melanotan II (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Peptide testing

Ordered GHK-Cu from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply